Skip to main navigation Skip to search Skip to main content

Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon - A multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril.

  • A.E. Gliddon
  • , C.J. Dore
  • , C.M. Black
  • , N. McHugh
  • , R. Moots
  • , C.P. Denton
  • , A. Herrick
  • , T. Barnes
  • , J. Camilleri
  • , K. Chakravarty
  • , P. Emery
  • , B. Griffiths
  • , N.D. Hopkinson
  • , P. Hickling
  • , P. Lanyon
  • , C. Laversuch
  • , T. Lawson
  • , R. Mallya
  • , M. Nisar
  • , C. Rhys-Dillon
  • T. Sheeran, P.J. Maddison

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)3837-3846
    JournalArthritis and Rheumatism
    Volume56
    Issue number11
    DOIs
    Publication statusPublished - 1 Nov 2007

    Keywords

    • RHEUMATOLOGY

    Cite this